TECAR Therapy in Physical Therapy and Postoperative Use
TECAR (Transfer of Energy Capacitive and Resistive) therapy is an emerging radiofrequency-based electrotherapy modality that can be safely used at postoperative day 19, and current evidence suggests it may accelerate pain reduction and functional recovery when integrated into your rehabilitation program.
What is TECAR Therapy?
TECAR is a deep heating therapy that uses high-frequency electromagnetic energy (radiofrequency) to generate heat within tissues 1. The technology works through two modes:
- Capacitive mode: Targets superficial tissues with higher water content (muscles, lymphatic system)
- Resistive mode: Penetrates deeper into tissues with lower water content (tendons, ligaments, bone)
The mechanism promotes tissue healing through enhanced microcirculation, reduced inflammation, pain relief, and stimulation of metabolic processes 1, 2.
Evidence for Postoperative Use
Your use of TECAR at day 19 post-op aligns with current rehabilitation principles. The 2023 Aspetar ACL rehabilitation guideline 3 states that "physical therapy modalities can be beneficial as an adjunct in the early phase of rehabilitation when pain and other post-operative issues are present," though it notes evidence for some modalities is conflicting.
Pain and Functional Benefits
The most recent meta-analysis (2022) demonstrates significant pain reduction with TECAR therapy 4:
- After 4 weeks: Standardized mean difference of -1.04 compared to control (P<0.001)
- After 8 weeks: Even greater effect at -1.80 (P<0.001)
- Intra-group improvements: Progressive pain reduction from 2 to 8 weeks of treatment
A 2025 study on trigger finger 2 showed that combining TECAR with conventional treatment produced "statistically significant, quicker, and higher magnitude improvements" compared to single treatments alone.
Clinical Applications Relevant to Post-Op Recovery
Recent evidence (2025-2026) demonstrates TECAR's effectiveness for:
- Acute musculoskeletal injuries: A 2026 study on acute hamstring injuries 5 showed TECAR reduced pain by 38.75%-63.33% compared to 2.81%-9.81% in rest-only controls, with improvements in flexibility
- Tissue healing and inflammation: Promotes tissue regeneration and reduces inflammation 1, 6
- Muscle tone normalization: Immediate reduction in muscle tension that persists at least 10 minutes post-treatment 7
- Improved circulation: Significant increases in perfusion index and blood flow 8
Treatment Considerations at Day 19 Post-Op
Safety Profile
- No contraindications at this timeframe if surgical wounds are healed
- The Aspetar guideline 3 cautions about dry needling before wound healing but does not list similar concerns for TECAR
- TECAR produces controlled thermal effects without the risks of invasive procedures
Optimal Integration
TECAR should be used as an adjunct to, not replacement for, exercise-based rehabilitation 3. The guideline emphasizes that "exercise interventions should be considered the foundation" of post-operative rehabilitation.
Your rehabilitation should prioritize:
- Progressive loading exercises (strength and motor control training)
- TECAR as adjunctive therapy for pain management and tissue healing acceleration
- Criterion-based progression rather than time-based alone
Common Pitfalls to Avoid
- Over-reliance on passive modalities: Don't let TECAR sessions replace active exercise progression 3
- Inconsistent protocols: Current research shows variability in treatment parameters; ensure your provider follows evidence-based dosing (typically 15-20 minutes per session, 1-3 times weekly) 9, 2
- Ignoring progression criteria: Time since surgery is "necessary but not sufficient" for advancement 3; combine TECAR with objective physical assessments
Evidence Limitations
The 2025 clinical commentary 1 acknowledges important gaps:
- Small sample sizes in most studies
- Lack of standardized treatment protocols
- Limited long-term efficacy data
- Need for cost-effectiveness analysis
However, the safety profile and emerging positive outcomes support its use as an adjunctive modality in your current post-operative phase.
Your provider's decision to incorporate TECAR at day 19 represents an evidence-informed approach to potentially accelerate your recovery, reduce pain, and improve tissue healing, provided it complements rather than replaces your active rehabilitation exercises.